CTTN and myeloid sarcoma: Lastly, Rho- and Rab2-GDI inhibitors, Cofilin, Cortactin and the Fibrinogen beta chain precursor can improve our knowledge of the pharmacodynamics of β-interferon and the pathophysiology of MS.